Faraday Future Signs up the First FF 91 2.0 Futurist Alliance User Post Final Launch, Continuing to Execute on Phase One of Its Delivery Plan
The first user of the Ultimate AI TechLuxury FF 91 vehicle has signed the first…
News
KB Home Announces the Grand Opening of Its Newest Community in Antioch, California
Wildwood at Laurel Ranch offers personalized, new homes close to desirable schools and outdoor recreation,…
Praxis Precision Medicines to Present at the 2023 Jefferies Healthcare Conference
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Praxis Precision Medicines to Present at the 2023 Jefferies Healthcare Conference
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
SciSparc Announces Successful Final Phase IIa Results, Meeting End Points of its Phase IIa Alzheimer Disease Patients with Agitation Trial
Topline results using the Company’s SCI-110 met the trial’s primary and secondary end points, demonstrating…
SciSparc Announces Successful Final Phase IIa Results, Meeting End Points of its Phase IIa Alzheimer Disease Patients with Agitation Trial
Topline results using the Company’s SCI-110 met the trial’s primary and secondary end points, demonstrating…
Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development
CALGARY, Alberta, June 02, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development
CALGARY, Alberta, June 02, 2023 (GLOBE NEWSWIRE) — Providence Therapeutics Holdings Inc. (“Providence”), a biopharmaceutical…
Bon Natural Life Limited Launches Three New Cruciferous Vegetable-Based Powder Drinks
XI’AN, China, June 02, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
Bon Natural Life Limited Launches Three New Cruciferous Vegetable-Based Powder Drinks
XI’AN, China, June 02, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII
BUFFALO, N.Y., June 02, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a…
22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII
BUFFALO, N.Y., June 02, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a…
Celldex Therapeutics to Present at Jefferies Healthcare Conference
HAMPTON, N.J., June 02, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
Celldex Therapeutics to Present at Jefferies Healthcare Conference
HAMPTON, N.J., June 02, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit…
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Kisqali is the first and only CDK4/6 inhibitor to demonstrate a consistent, clinically meaningful benefit…
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Freeline to Present at 2023 Jefferies Healthcare Conference
LONDON, June 02, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its…
Freeline to Present at 2023 Jefferies Healthcare Conference
LONDON, June 02, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that its…